&lt;Praxis Biologics Inc> said itfiled a registration statement with the Securities and ExchangeCommission for the initial public offering of 1.5 mln shares ofcommon.    It said the offering is being managed by Shearson LehmanBrothers Inc and Merrill Lynch Capital Markets.    Praxis said it will use the proceeds to fund productresearch and development costs and initially will focus onvaccines for infants and young children. Reuter&#3;